These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22098075)

  • 1. Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis.
    Gioulbasanis I; Patrikidou A; Kitikidou K; Papadimitriou K; Vlachostergios PJ; Tsatsanis C; Margioris AN; Papandreou CN; Mavroudis D; Georgoulias V
    Nutr Cancer; 2012; 64(1):41-7. PubMed ID: 22098075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis.
    Gioulbasanis I; Georgoulias P; Vlachostergios PJ; Baracos V; Ghosh S; Giannousi Z; Papandreou CN; Mavroudis D; Georgoulias V
    Lung Cancer; 2011 Dec; 74(3):516-20. PubMed ID: 21632145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
    Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
    Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).
    Dehing-Oberije C; Aerts H; Yu S; De Ruysscher D; Menheere P; Hilvo M; van der Weide H; Rao B; Lambin P
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):360-8. PubMed ID: 20888135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis.
    Orditura M; De Vita F; Catalano G; Infusino S; Lieto E; Martinelli E; Morgillo F; Castellano P; Pignatelli C; Galizia G
    J Interferon Cytokine Res; 2002 Nov; 22(11):1129-35. PubMed ID: 12513912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.
    De Vita F; Orditura M; Auriemma A; Infusino S; Roscigno A; Catalano G
    Oncol Rep; 1998; 5(3):649-52. PubMed ID: 9538169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer.
    Vlachostergios PJ; Gioulbasanis I; Ghosh S; Tsatsanis C; Papatsibas G; Xyrafas A; Hatzidaki E; Vasiliou C; Kamposioras K; Agelaki S; Margioris AN; Nasi D; Georgoulias V; Papandreou CN
    Clin Transl Oncol; 2013 Nov; 15(11):903-9. PubMed ID: 23463594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidant stress and B vitamins status in patients with non-small cell lung cancer.
    Tsao SM; Yin MC; Liu WH
    Nutr Cancer; 2007; 59(1):8-13. PubMed ID: 17927496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multivariate survival analysis for 423 patients with non-small cell lung cancer].
    Wang W; Rong TH; Zhang L; Jiang WQ; Xu GC; Huang HQ; He YJ; Guan ZZ
    Ai Zheng; 2003 Jun; 22(6):624-8. PubMed ID: 12948414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
    Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
    Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of nutritional Status in lung cancer using bio electrical impedance analysis and mini nutritional assessment].
    Daghfous H; El Ayeb W; Alouane L; Tritar F
    Tunis Med; 2014 Dec; 92(12):737-42. PubMed ID: 25879599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.